Looking to lead a stronger, healthier life?
Sign up for our Wellness Wire newsletter for all sorts of nutrition, fitness, and wellness wisdom.

Now we’re in this together.
Thanks for subscribing and having us along on your health and wellness journey.

See all Healthline's newsletters »
It's a Type 2 Life
It's a Type 2 Life

San Francisco Bay Area resident Patrick Totty writes about his experiences living with type 2 diabetes

See all posts »

The Panic in Needle Park

"The Panic in Needle Park” was the name of a 1971 film about an ill-fated love affair between two New York City heroin addicts. (It featured a young actor named Al Pacino in his second-ever Hollywood role.)

By 2022, however, that title might apply to the cohort of companies that manufacture the pens and needles medical patients use to inject drugs. A British information company study predicts that 10 years from now the worldwide market for needle-free injection devices will be worth $4.49 billion—more than quadruple its size in 2011.

What’s driving the spread of “needle-free injection” (NFI), says London-based visiongain (small v) in its report, “Medical Device Leader Series: Top Needle-Free Injection Device Manufacturers 2012-2022,” is a combination of factors.

Once an expensive manufacturing proposition, needle-free injection devices have become popular enough that the cost of producing them is coming down.

Add to that an increase in the number and types of drugs and substances that NFI technology can handle, including vaccines, hormones, and anesthetics.

Most important is the rapidly growing market for pain-free injection technology. As diabetes reaches epidemic proportions in some parts of the world, the number of people who are put off by the prospect of painful self-injections increases dramatically.

So the expected high growth of the NFI market is a good thing. The ability to take necessary drugs painlessly will grow the number of type 2s who are willing to take up insulin therapy but had been holding off doing so out of concerns over needles. It will certainly increase compliance, making it easier for patients to stick to a drug-taking schedule.

In a perfect world, of course, we could all take insulin orally. The problem with that has always been the delicate molecular structure of insulin. Think of insulin as a soufflé and the digestive system as an oven door that an inept cook has just slammed closed with the loudest, most resounding thwack imaginable. Buh-bye, insulin!

The probable way around this—and people are working on it right now—would be to somehow encase insulin in a saliva and digestive enzyme-proof “carrying case” that can protect it on its journey to the small intestine where blood can transport it intact to the rest of the body.

Until that day, though, needle-free sounds pretty good to me.



  • 1

Tags: Drugs

Was this article helpful? Yes No

Recommended for You

  • Do Sulfonylureas Add to Cardiovascular Risks?

    By: Patrick Totty
    Nov 13, 2012

    One of the challenges to having type 2 is trying to stay abreast of new research about the disease. That’s why routinely checking out sites like Healthline on the Internet can be a big help when it comes to talking to your doctor or endocrinolo...

    Read more »

  • Tomorrow Belongs to Us

    By: Patrick Totty
    Nov 08, 2012

    Every one of us who has diabetes, and the people who love us, hope for the day when science finds a way to cure our disease. Not just kick it into remission, but cure. In the meantime, until that great day, it’s good to remember just how ...

    Read more »

  • Small A1c Drop, Big Life Expectancy Gain

    By: Patrick Totty
    Nov 01, 2012

    While controversy swirls around what A1c percentage is ideal for type 2s, no one denies that lower is better. Currently, the recommended A1c target is 6.5%, equivalent to a daily average of140 mg/dL. For older people who’ve been diagnosed for...

    Read more »

  • Hitting the Road with Type 2

    By: Patrick Totty
    Sep 12, 2012

    My wife and I will soon be driving out from the San Francisco Bay Area to southern Utah. We haven’t visited the glorious red rock country there in years, so we’ve been anticipating this trip for months. Our goal is to shun freeways and inter...

    Read more »


About the Author

Bay Area resident Patrick Totty was diagnosed with type 2 diabetes in July, 2003.

Recent Blog Posts